Table 3.
Impact of vascular risk factors and comorbidities on CVR parameters in patients with type 1 diabetes
| n | VMRr (%) |
BHI |
|||||
|---|---|---|---|---|---|---|---|
| Present | Absent | P | Present | Absent | P | ||
| Hyperlipidemia | 36 | 80.8 | 88.8 | 0.5 | 1.62 | 1.65 | 0.2 |
| Hypertension | 10 | 80.6 | 83.0 | 0.90 | 1.65 | 1.67 | 0.88 |
| Neuropathy | 12 | 82.5 | 81.5 | 0.49 | 1.58 | 1.65 | 0.34 |
| Retinopathy | 26 | 82.3 | 92.3 | 0.09 | 1.47 | 1.72 | 0.08 |
| Nephropathy | 10 | 73.9 | 83.5 | 0.029 | 1.37 | 1.69 | 0.036 |
| ACE inhibitor or angiotensin receptor blocker treatment | 9 | 77.6 | 83.2 | 0.32 | 1.61 | 1.65 | 0.56 |
| Statin treatment | 4 | 77.1 | 82.7 | 0.31 | 1.50 | 1.62 | 0.36 |
Data are median values.